Table 7
From: Cost-utility analysis of a national project to reduce hypertension in Israel
Appendix III: Key Utilization variables. | Â | Â | Reference/Data Source |
|---|---|---|---|
UTILIZATION | Â | Both Genders | |
Hypertension Treatment | Â | Â | Â |
% of persons transferred to NPC of hypertension | Â | 50% | 9 |
Existing ambulatory visits in first year for hypertension | Â | 1.0 | Barzelai Hospital |
Existing annual maintenance visits for hypertension | Â | 0.5 | Barzelai Hospital |
Annual maintenance visits in program | Â | 2.0 | 9 |
Average time of visit (minutes) | Â | 15 | 9 |
| Â | Males | Females | Â |
AMI Treatment | Â | Â | Â |
GP visits in three years prior to AMI | 10 | 10 | Assumption |
% AMI that are catheterised | 72% | 59% | 14 |
% AMI getting stent/baloon (primary PCI) | 19% | 14% | 14 |
% AMI getting stent (late PCI) | 38% | 32% | 14 |
% AMI getting CABG | 8% | 4% | 14 |
% AMI being discharged after catheterisation | 7% | 9% | 14 |
% AMI being discharged with no catheterisation | 5% | 22% | 14 |
% AMI with Thrombolysis | 23% | 19% | 14 |
% AMI rehospitalised for cardiac reasons in month | 15.4% | 15.7% | 14 |
% ratio of cyphers to all cypher-stent usage | 40.0% | 40.0% | MOH Medical Technology Assesment Dept. |